At the news
? BEARISHIMPACT 5/10 CLUSTER filed Feb 22, 2026 at 19:00 ET
Multiple C-suite executives at Vir Biotechnology, including the CEO, CFO, and General Counsel, conducted open-market share sales over the past week, totaling $404,942 in sales proceeds. These transactions coincide with a routine grant of stock awards worth $0 in value. The selling represents modest insider divestment by top executives.
- CEO Marianne De Backer sold 33,801 shares for $282,614 in open-market transactions.
- CFO Jason O'Byrne and General Counsel Vanina de Verneuil each sold 2,089 and 21,262 shares, respectively, netting $15,569 and $197,375 total.
- Five C-suite insiders sold shares in open market, aggregating $404,942 in total proceeds.
- All sales occurred between $7.45 and $9.82 per share, with higher prices on later dates.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access